Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4794130
Max Phase: Preclinical
Molecular Formula: C63H98F6N2O13P2
Molecular Weight: 1122.45
Molecule Type: Unknown
Associated Items:
ID: ALA4794130
Max Phase: Preclinical
Molecular Formula: C63H98F6N2O13P2
Molecular Weight: 1122.45
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C(=O)CCCCCCC[P+](c2ccccc2)(c2ccccc2)c2ccccc2)[C@H](C)[C@@H](O)[C@]1(C)O.F[P-](F)(F)(F)(F)F
Standard InChI: InChI=1S/C63H98N2O13P.F6P/c1-14-51-63(10,72)56(68)45(6)65(52(66)35-27-16-15-17-28-36-79(47-29-21-18-22-30-47,48-31-23-19-24-32-48)49-33-25-20-26-34-49)40-41(2)38-61(8,71)58(78-60-54(67)50(64(11)12)37-42(3)74-60)43(4)55(44(5)59(70)76-51)77-53-39-62(9,73-13)57(69)46(7)75-53;1-7(2,3,4,5)6/h18-26,29-34,41-46,50-51,53-58,60,67-69,71-72H,14-17,27-28,35-40H2,1-13H3;/q+1;-1/t41-,42-,43+,44-,45-,46+,50+,51-,53+,54-,55+,56-,57+,58-,60+,61-,62-,63-;/m1./s1
Standard InChI Key: IAJQUBZOAVHIML-KDSZLNFNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1122.45 | Molecular Weight (Monoisotopic): 1121.6801 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Cochrane EJ,Hulit J,Lagasse FP,Lechertier T,Stevenson B,Tudor C,Trebicka D,Sparey T,Ratcliffe AJ. (2021) Impact of Mitochondrial Targeting Antibiotics on Mitochondrial Function and Proliferation of Cancer Cells., 12 (4.0): [PMID:33859798] [10.1021/acsmedchemlett.0c00632] |
Source(1):